Back
United Therapeutics Stock Price Chart
Sponsored
UTHR
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
49
UTHR
United Therapeutics
Last Price:
$363.39
Seasonality Move:
6.42%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing slight selling pressure.
United Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 364.41 | Sell |
20-day SMA: | 368.45 | Sell |
50-day SMA: | 370.25 | Sell |
200-day SMA: | 315.65 | Buy |
8-day EMA: | 364.17 | Sell |
20-day EMA: | 367.41 | Sell |
50-day EMA: | 366.29 | Sell |
200-day EMA: | 324.96 | Buy |
United Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.54 | Sell |
Relative Strength Index (14 RSI): | 43.55 | Sell |
Chaikin Money Flow: | -426431 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (361 - 373.72) | Sell |
Bollinger Bands (100): | (338.58 - 376.24) | Buy |
United Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 359.58 while UTHR 8-day simple moving average is 364.41, which is a Sell signal.
-
The stock price of UTHR is 359.58 while United Therapeutics 20-day SMA is 368.45, which makes it a Sell.
-
United Therapeutics 50-day simple moving average is 370.25 while UTHR share price is 359.58, making it a Sell technically.
-
UTHR stock price is 359.58 and United Therapeutics 200-day simple moving average is 315.65, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Sell
49
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a SellThe current United Therapeutics [UTHR] share price is $359.58. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
United Therapeutics Stock Info
Market Cap:
16.1B
Price in USD:
359.58
Share Volume:
925.6K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
208.62
Sell
49
United Therapeutics (UTHR)
is a Sell
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 359.58 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 359.58 while UTHR 8-day exponential moving average is 364.17, which is a Sell signal.
-
The stock price of UTHR is 359.58 while United Therapeutics 20-day EMA is 367.41, which makes it a Sell.
-
United Therapeutics 50-day exponential moving average is 366.29 while UTHR share price is 359.58, making it a Sell technically.
-
UTHR stock price is 359.58 and United Therapeutics 200-day simple moving average is 324.96, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.70 per share, and an increase next year of $2.67 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is -2.54, suggesting United Therapeutics is a Sell
-
United Therapeutics Relative Strength Index (RSI) is 43.55, which suggest United Therapeutics is oversold
-
The Bollinger Bands (25) for United Therapeutics is (361 - 373.72), which suggest United Therapeutics is a Buy
-
The Bollinger Bands (100) for United Therapeutics is (338.58 - 376.24), which suggest United Therapeutics is a Buy
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.